Pricing Log in Create free account

Rallybio Corporation (RLYB) vs Tenaya Therapeutics, Inc. (TNYA)

Rallybio Corporation and Tenaya Therapeutics, Inc. are both Biotechnology companies. Rallybio Corporation and Tenaya Therapeutics, Inc. are of similar size ($91.6M and $89.1M). Tenaya Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.0×. Across the 10 metrics below, Rallybio Corporation leads on 8 and Tenaya Therapeutics, Inc. on 2.

Valuation

Metric RLYB TNYA Biotechnology median
P/E 2.02 n/m 8.50
P/S 108.13 n/m 9.71
P/B 0.98 1.16 2.13
Price to free cash flow 3.48 n/m 20.82
EV/EBITDA 0.00 n/m 0.64
EV/Sales (0.08) n/m 9.21
Earnings yield 49.50% (143.24%) (33.15%)
Free cash flow yield 28.76% (65.32%) (25.50%)

Profitability

Metric RLYB TNYA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 64.86% (121.86%) (56.36%)
Return on assets 61.12% (95.61%) (48.04%)
Return on invested capital (1,052.03%) 0.00% 0.00%

Growth

Metric RLYB TNYA Biotechnology median
Revenue growth (TTM) 1.18% — 6.02%
EPS growth (last fiscal year) 85.06% 54.96% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RLYB TNYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 27.26 4.52 4.72
Net debt to EBITDA 1.63 1.19 0.96

Dividend

Metric RLYB TNYA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric RLYB TNYA Biotechnology median
Market cap 89.08m 91.57m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack